Clinical Trial Update: Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating concurrent subcutaneous basal insulin and intravenous insulin pump therapy in hyperglycemic crisis patients in critical care…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Ketoacidosis
• Hyperglycaemic Crisis in Diabetes Mellitus
• Hyperglycaemic Hyperosmolar Nonketotic Syndrome

Drugs mentioned

• intravenous insulin pump therapy (intravenous insulin)
• subcutaneous basal insulin (basal insulin)

Snippet

Sponsor: Changhua Christian Hospital | Conditions: Hyperglycaemic Crisis in Diabetes Mellitus, Diabetic Ketoacidosis | Phase 2 | Status: UNKNOWN